calcimedica inc glp-1 receptor agonists weight management diabetes treatments How Did Medications Become Loss Meds? Beyond Journal Club on SURMOUNT-1 Trial – Core IM Podcast Efficacy and Safety of Glucagon-Like
Description
11 A study has shown that GLP-1Rs are increased in the visceral adipose tissue of morbidly obese patients with insulin resistance
doi:10.3945/ajcn.116.135673
The pancreas and liver make more insulin when they need to and less glucagon when they don't
The study showed a 20% risk reduction of the primary outcome in the GLP-1 RA arm (HR 0.80
Figure 1 Figure 2 2 Neuroendocrine imbalance More recently, attention has been widely paid to the role of the neuroendocrine backdrop in the development of PCOS ( Figure 3 )
